Nitrazepam (NTR), a potent benzodiazepine, is used for the short-term relief of symptoms of anxiety or anxiety associated with depression. Because of its poor water solubility and extensive metabolism in the liver into pharmacologically inactive glucuronides, NTR oral therapy is associated with a slow onset of drug action. Generally, compounds with very low aqueous solubility are considered to have dissolution rate-limited absorption and hence poor absorption, distribution, and target organ delivery.

In present investigation, a fast- dissolving form of the compound with a high level of aqueous solubility is desirable for rapid absorption of the drug during oral benzodiazepine therapy. Complexation of such drugs with cyclodextrin (CDs) represents one way to achieve that goal.

Materials and Methods {#sec1-1}
=====================

Stoichiometric ratio was determined by phase solubility method and complex was prepared using kneading, spray drying and lyophilization. The complexes were characterized by differential scanning calorimetry, fourier-transform infrared spectroscopy, scanning electron microscopy, and powder X-ray diffraction studies, drug content, wettability, dissolution and parameter for tabletting efficiency.

Results and Discussion {#sec1-2}
======================

Phase solubility analysis has been among the preliminary requirements for optimizing the development of inclusion complexes of drugs as it permits the evaluation of the affinity between a CD and drug molecule in water. Increased solubility may be due to improved dissolution of NTR particles in water due to the presence of CDs. The solubility of NTR increased by 218-fold at 37°C and 158-fold at 25°C and121-fold at 37°C and 72-fold at 25°C at a 200 mM concentration of SBE-β-CD and HP β-CD respectively. This curve indicated an increase in the solubility of NTR with an increase in the concentration of the CD in water. Increasing the amount of the CD increased the amount of NTR entering the water, improving the aqueous solubility of NTR.

Gibbs free energy values were all negative, indicating the spontaneous nature Nitrazepam solubilization and their value decreased with increase in the cyclodextrin concentration, demonstrating that the reaction conditions became more favorable as the concentration of cyclodextrin increased.

Drug content of HPβCD and SBEβCD formulations was found to be 85% and 96%, respectively. The results of DSC and FTIR study showed that Nitrazepam was compatible with both cyclodextrins and complex formed by spray drying and lyophilization is best. The results of wettability, dissolurion and *in vitro* release study were shown in [Figure 1](#F1){ref-type="fig"}.
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Conclusion {#sec1-3}
==========

Solubility studies revealed a significant increase in the aqueous solubility of NTR with an increase in the concentration of HP-β-CD and SBE-β-CD. The maximum concentration of HP- β -CD and SBE-β-CD studied (200 mM at 37°C) resulted in 121-fold and 218-fold improvement in the saturation solubility of Nitrazepam. An inclusion complex of Nitrazepam with HP-β-CD and SBE-β-CD at a molar ratio of 2:1 was successfully prepared by kneading, spray-drying, and lyophilization. This was confirmed by DSC, FTIR, SEM, and XRD studies. The greatest improvement in solubility and *in vitro* drug release was observed with an inclusion complex prepared with SBE-β-CD by lyophilization. The solubility and *in vitro* drug release of a physical mixture improved to a lesser degree than did that of complexes prepared by kneading, spray-drying, and lyophilization. These finding are extremely important from commercial point of view as the prepared complex remedies the drawback of NTR\'s poor dissolution profile.\[[@ref1]\]
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